Landos Biopharma Inc (LABP)
22.93 +0.13 (+0.58%) 05/24/24 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
for Thu, May 23rd, 2024
Results
download Want to compare other data? Select FieldsSymbol | LABP | MIST | XCUR | ||
Company | Landos Biopharma Inc | Milestone Pharmaceuticals Inc | Exicure Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 22.93 | 1.3400 | 11.12 | ||
High | 22.94 | 1.3500 | 11.12 | ||
Low | 22.75 | 1.2800 | 11.12 | ||
Last | 22.93 | 1.2900 | 11.12 | ||
Change | +0.13 | -0.0600 | +0.12 | ||
% Change | +0.58% | -4.44% | +1.09% | ||
Volume | 50,800 | 115,359 | 807 | ||
20-Day Average Volume | 11,285 | 1,873,611 | 26,460 | ||
Previous Close | 22.80 | 1.3500 | 11.00 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | Yes | No | ||
Technicals | |||||
20-Day Moving Average | 22.35 | 0.9191 | 11.58 | ||
20-Day Raw Stochastic | 99.03% | 91.89% | 46.66% | ||
20-Day Relative Strength | 81.09% | 50.09% | 47.46% | ||
Weighted Alpha | +234.26 | -1.06 | -66.41 | ||
Today's Opinion | 100% Buy | 72% Sell | 16% Buy | ||
Previous Opinion | 100% Buy | 72% Sell | 16% Buy | ||
Last Month's Opinion | 100% Buy | 16% Sell | 88% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | +2.83% since 05/16/24 | +23.58% since 04/22/25 | -3.17% since 04/22/25 | ||
Low | 22.20 on 05/20/24 | 1.0900 on 04/24/25 | 10.70 on 04/24/25 | ||
High | 22.94 on 05/23/24 | 1.3700 on 04/28/25 | 12.65 on 04/23/25 | ||
1-Month | |||||
%Chg | +3.52% since 04/23/24 | +48.86% since 03/28/25 | -21.37% since 03/28/25 | ||
Low | 21.91 on 05/02/24 | 0.6300 on 04/09/25 | 8.28 on 04/17/25 | ||
High | 22.94 on 05/23/24 | 1.3700 on 04/28/25 | 14.11 on 04/01/25 | ||
3-Month | |||||
%Chg | +264.55% since 02/23/24 | -34.50% since 01/29/25 | +2.52% since 01/29/25 | ||
Low | 5.57 on 03/11/24 | 0.6300 on 04/09/25 | 7.18 on 02/25/25 | ||
High | 22.94 on 05/23/24 | 2.4991 on 03/17/25 | 15.91 on 03/20/25 | ||
6-Month | |||||
%Chg | +418.78% since 11/22/23 | -8.39% since 10/29/24 | +326.36% since 10/29/24 | ||
Low | 3.21 on 12/22/23 | 0.6300 on 04/09/25 | 2.44 on 11/06/24 | ||
High | 22.94 on 05/23/24 | 2.7500 on 12/31/24 | 36.00 on 11/27/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 71,674 | 72,028 | 69,496 | ||
Shares Outstanding, K | 3,126 | 53,354 | 6,318 | ||
Annual Sales | 0 | 0 | 500,000 | ||
Annual Net Income | -21,940,000 | -41,520,000 | -9,700,000 | ||
Last Quarter Sales | 0 | 0 | 0 | ||
Last Quarter Net Income | -8,900,000 | -12,360,000 | -7,180,000 | ||
60-Month Beta | 0.14 | 1.38 | 3.74 | ||
Per-Share Information | |||||
Most Recent Earnings | -1.43 on 05/09/24 | -0.19 on 03/13/25 | -3.39 on 03/18/25 | ||
Latest Earnings Date | 05/10/24 | 05/12/25 | 06/16/25 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |